Prospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Feb 7, 2017; 23(5): 906-918
Published online Feb 7, 2017. doi: 10.3748/wjg.v23.i5.906
Table 1 Baseline characteristics of patients with portal vein tumor thrombosis in our series
PatientAge/sexPS:E/KCirrhosis etiologyChild-Pugh classAFP (ng/mL)Albumin (g/100 mL)INRBilirubin (mg)PLT (n/μL)EGDSComorbidities
EV, GV, RS
164 yr/M2/70HCVA6143.71.101.20%75000F1-EV, GV-, RS-Diabetes
254 yr/M1/80HCVB7843.21.401.40%62000F2-EV, GV+, RS-Diabetes, MI, COPD
385 yr/M1/80HCVA5324.21.141.20%125000F!-EV, GV-, RS-None
475 yr/M2/70HCVA6653.61.321.00%88000F2-EV, GV-, RS-Thyroid carcinoma, COPD
561 yr/F0/100HCVA5474.01.250.90%74000EV-, GV-, RS-Diabetes, hypertension
677 yr/M2/70HCVB7163.51.551.30%56000F1-EV, GV-, RS-Diabetes
Table 2 Hepatocellular carcinoma patterns, treatments and results in 6 patients with portal vein tumor thrombosis treated with electrochemotherapy
PatientPrevious treatmentsSite of PVTTHCC nodules/sizeResults of ECTFollow-up
1Surgery, RFARight PV, distal main PV-Complete necrosis of Vp3-Vp4 PVTT20 mo
Complete recanalization
2NoneRight PV, distal main PV1 nodule/3.5 cmComplete necrosis of Vp3-Vp4 PVTTDeath for rupture of esophageal varices 14 mo after ECT
Complete recanalization
3NoneRight PV1 nodule/3 cmComplete necrosis of Vp3-Vp4 PVTTDeath for Liver failure
Persistent shrinked bland thrombosis14 mo after ECT
4RFARightPV, left PV, distal main PV2 nodules/1.5 and 2.5 cmComplete necrosis of Vp3-Vp4 PVTTDeath 5 wk after ECT for rupture of esophageal varices
Persistent shrinked bland thrombosis
5NoneLeft PV1 nodule/3.5 cmComplete necrosis of Vp3-Vp4 PVTT12 mo
Persistent shrinked bland thrombosis
6Surgery, RFA, TACERight PV-Complete necrosis of Vp3-Vp4 PVTT9 mo
Persistent shrinked bland thrombosis

  • Citation: Tarantino L, Busto G, Nasto A, Fristachi R, Cacace L, Talamo M, Accardo C, Bortone S, Gallo P, Tarantino P, Nasto RA, Di Minno MND, Ambrosino P. Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility study. World J Gastroenterol 2017; 23(5): 906-918
  • URL: https://www.wjgnet.com/1007-9327/full/v23/i5/906.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v23.i5.906